IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 253.00
Bid: 251.00
Ask: 254.00
Change: 5.00 (2.02%)
Spread: 3.00 (1.195%)
Open: 248.00
High: 253.00
Low: 246.00
Prev. Close: 248.00
GFRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Settlement of AWPR

23 Dec 2019 11:00

RNS Number : 8332X
Galliford Try PLC
23 December 2019
 

 

 

 

 

 

 

Galliford Try plc

Settlement agreed on Aberdeen Western Peripheral Route

 

Galliford Try plc ("Galliford Try"), the housebuilding, regeneration and construction group announces that, following a lengthy period of negotiation, the Aberdeen Western Peripheral Route ("AWPR") joint venture has substantially agreed settlement terms with the client in respect of the final account of this major infrastructure project. As a result of the settlement Galliford Try expects to receive a cash payment of around £32m and incur a write-off of £52m.

 

The settlement brings to a conclusion a complex and challenging project, averting a lengthy and costly litigation process. The settlement also removes a significant distraction and uncertainty, allowing the Construction business to focus on its core business, current and new projects which are expected to deliver improving margins, operating on multiple secured frameworks and in our chosen sectors. 

 

Taken together with an adverse adjudication award on an unrelated historical contract in the period, the Group will report an exceptional write-off of circa £61m at 31 December 2019.

 

The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary. This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014.

 

For further enquiries please contact:

 

Galliford Try

Graham Prothero, Chief Executive 01895 855001

Andrew Duxbury, Finance Director

 

Tulchan Communications

James Macey White 020 7353 4200

Martin Pengelley

Elizabeth Snow

 

 

Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2019, the Group generated revenue of £2.8bn. On 7 November 2019 the Group announced it had entered into an agreement with Bovis Homes Group PLC regarding a combination of Bovis Homes and the Group's housebuilding businesses, Linden Homes and Partnerships & Regeneration. The transaction is expected to complete on 3 January 2020.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBXLFLKLFEFBK
Date   Source Headline
17th Nov 20227:00 amRNSTransaction in Own Shares
16th Nov 20224:40 pmRNSSecond Price Monitoring Extn
16th Nov 20224:35 pmRNSPrice Monitoring Extension
16th Nov 20227:00 amRNSTransaction in Own Shares
11th Nov 20223:45 pmRNSResult of AGM
11th Nov 20227:00 amRNSAGM Statement
10th Nov 20224:15 pmRNSDirector/PDMR Shareholding
8th Nov 20226:00 pmRNSHolding(s) in Company
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSTransaction in Own Shares
31st Oct 20225:35 pmRNSTotal Voting Rights
26th Oct 20227:00 amRNSContract
25th Oct 20224:15 pmRNSDirector/PDMR Shareholding
25th Oct 20227:00 amRNSTransaction in Own Shares
24th Oct 20224:15 pmRNSHolding(s) in Company
24th Oct 20227:00 amRNSTransaction in Own Shares
20th Oct 202210:00 amRNSDirector/PDMR Shareholding
20th Oct 20227:00 amRNSTransaction in Own Shares
12th Oct 20227:00 amRNSTransaction in Own Shares
11th Oct 20227:00 amRNSTransaction in Own Shares
10th Oct 20224:00 pmRNSAnnual Financial Report
7th Oct 20224:00 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSTransaction in Own Shares
4th Oct 20227:00 amRNSTotal Voting Rights
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
28th Sep 20225:30 pmRNSDirector/PDMR Shareholding
28th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20225:03 pmRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20224:45 pmRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSTransaction in Own Shares
22nd Sep 20223:00 pmRNSEmployee Share Trust Trading Plan
22nd Sep 20227:00 amRNSTransaction in Own Shares
21st Sep 20227:01 amRNSLaunch of Share Buyback Programme
21st Sep 20227:00 amRNSFinal Results
1st Aug 20227:00 amRNSContract
14th Jul 20227:00 amRNSTrading Statement
11th Jul 20227:00 amRNSAcquisition of MCS Control Systems
1st Jul 202211:00 amRNSDirector Declaration
23rd Jun 20227:00 amRNSContract
31st May 20227:00 amRNSTotal Voting Rights
30th May 202210:00 amRNSExercise of share options
10th May 20227:00 amRNSBusiness Briefing
26th Apr 20227:00 amRNSAppointment of Director
1st Apr 20229:10 amRNSConfirmation of Directorate Change
15th Mar 20227:00 amRNSDirectorate Change
4th Mar 20225:03 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSHalf-year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.